Evidence map›Paper›PMID 41993274›Full record

ArticlebioRxiv : the preprint server for biology2026

From bats to humans: uncovering

Eugenia Martin-Vazquez, Xiaoyan Yi, Maressa Fernandes Bonfim, Sayro Jawurek, Priscila L Zimath, Arturo Roca-Rivada, Junior Garcia Oliveira, Jose Maria Costa-Junior, François Pattou, Julie Kerr-Conte and 9 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Eugenia Martin-VazquezULB Center for Diabetes Research, Medical Faculty, Université Libre De Bruxelles (ULB), Brussels, Belgium.
Xiaoyan YiULB Center for Diabetes Research, Medical Faculty, Université Libre De Bruxelles (ULB), Brussels, Belgium.
Maressa Fernandes BonfimULB Center for Diabetes Research, Medical Faculty, Université Libre De Bruxelles (ULB), Brussels, Belgium.
Sayro JawurekULB Center for Diabetes Research, Medical Faculty, Université Libre De Bruxelles (ULB), Brussels, Belgium.
Priscila L ZimathULB Center for Diabetes Research, Medical Faculty, Université Libre De Bruxelles (ULB), Brussels, Belgium.
Arturo Roca-RivadaULB Center for Diabetes Research, Medical Faculty, Université Libre De Bruxelles (ULB), Brussels, Belgium.
Junior Garcia OliveiraULB Center for Diabetes Research, Medical Faculty, Université Libre De Bruxelles (ULB), Brussels, Belgium.
Jose Maria Costa-JuniorULB Center for Diabetes Research, Medical Faculty, Université Libre De Bruxelles (ULB), Brussels, Belgium.
François PattouTranslational Research for Diabetes, Inserm U1190, CHU Lille, Institut Pasteur Lille, University of Lille, Lille, France.
Julie Kerr-ConteTranslational Research for Diabetes, Inserm U1190, CHU Lille, Institut Pasteur Lille, University of Lille, Lille, France.
Montserrat NacherHospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), L'Hospitalet de Llobregat, Barcelona, Spain.
Eduard MontanyaHospital Universitari de Bellvitge, Bellvitge Biomedical Research Institute (IDIBELL), and Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), L'Hospitalet de Llobregat, Barcelona, Spain.
Erwin IlegemsNovo Nordisk Research Center, Novo Nordisk A/S, 2760 Maaloev, Denmark.
Johnna D WesleyNovo Nordisk US R&D, Lexington, MA, 02128 United States.
Alexandra C TitleInSphero AG, Schlieren 8952, Switzerland.
Burcak YesildagInSphero AG, Schlieren 8952, Switzerland.
Tzachi HagaiShmunis School of Biomedicine and Cancer Research, Tel Aviv University, Tel-Aviv 6997801, Israel.
Anne Op de BeeckULB Center for Diabetes Research, Medical Faculty, Université Libre De Bruxelles (ULB), Brussels, Belgium.
Decio L EizirikULB Center for Diabetes Research, Medical Faculty, Université Libre De Bruxelles (ULB), Brussels, Belgium.

Funding

The Integrated Stress Response in Human Islets During Early T1DU01DK127786 · NIDDK · UNIVERSITY OF CHICAGO · PI EVANS-MOLINA, CARMELLA, MIRMIRA, RAGHAVENDRA G · 2020 to 2025
$7.1M
Implications of Changes in Islet Exosomal Cargo in Type 1 DiabetesR01DK133881 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI EVANS-MOLINA, CARMELLA, MIRMIRA, RAGHAVENDRA G · 2022 to 2025
$2.7M
iPLA2beta-mediated alternative splicing and -cell death in type 1 diabetesR01DK126444 · NIDDK · UNIVERSITY OF VIRGINIA · PI CHALFANT, CHARLES E., EIZIRIK, DECIO LAKS · 2021 to 2024
$2.0M
NIDDK NIH HHS R01 DK126444NIDDK NIH HHS R01 DK133881NIDDK NIH HHS U01 DK127786
6 · The paper itself

Abstract

Viral infections are one of the main environmental factors triggering type 1 diabetes (T1D). Pancreatic alpha cells are more resistant than beta cells to diabetogenic viruses, partially explaining their survival in T1D. Similarly, bats have enhanced viral resistance, suggesting putative convergent evolution in antiviral mechanisms. Herein, we compared global gene expression in bat fibroblasts under basal conditions or exposed to double-stranded RNA to human alpha and beta cells and found that alpha cells exhibit greater similarity than beta cells to the antiviral responses of bat cells, as well as stronger intrinsic resistance to viral infection. Interferon-stimulated gene 15 (ISG15), a key regulator of antiviral responses in humans and bats, has higher expression in alpha compared to beta cells in five single-cell RNASeq datasets from human islet cells and in human induced pluripotent stem cell (hiPSC)-derived alpha-like cells.

Identifiers

PMID41993274
PMCPMC13081969

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.